Fundraising FoxBioMarker Strategies
Rockville, US · Maryland LLC · 2 known investors
Find your way into BioMarker Strategies
Sign up to see every warm intro you have to BioMarker Strategies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioMarker Strategies team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
GM
Glenn MillerBoard director
SA
Scott AlloccoBoard director
KK
Katarzyna KusmierzBoard director
DC
Douglas ClarkBoard director
JD
Jack DavisBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$525K disclosed across 1 of 2 rounds · 2015–2016
▶$525KraisedSep 2016 · 2 investors · BiotechnologyRule 506(b)
▶$525KraisedSep 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Katarzyna KusmierzDirector
- Jerry ParrottExecutive Officer, Director
- Jack DavisDirector
- Scott AlloccoDirector
- Glenn MillerDirector
- Douglas ClarkDirector
- Amount sold
- $525K
- Minimum investment
- $25K
- First sale
- Aug 2016
- Incorporated
- Limited Liability Company, Maryland
- Federal exemptions
- 06b
▶Undisclosed amountofferedAug 2015 · 2 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedAug 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Glenn MillerDirector
- Jerry ParrottExecutive Officer, Director
- Scott AlloccoDirector
- Katarzyna KusmierzDirector
- Douglas ClarkDirector
- Jack DavisDirector
- Minimum investment
- $25K
- First sale
- Aug 2015
- Incorporated
- Limited Liability Company, Maryland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Cartography BiosciencesCartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets. The company combines genomics data analysis with therapeutic design to create more targeted treatments for cancer patients.
Bio StrategyDistributor of scientific instrumentation and laboratory consumables serving food and beverage manufacturers, production, and materials science customers across Australia and New Zealand. Offers equipment and services for physical and chemical characterisation, life science, sample preparation, and general lab needs.
Companies working in the same space as BioMarker Strategies.
Non-dilutive funding · 9 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $299.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $223.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $299.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $192.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2009 | $254.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are BioMarker Strategies's investors?
- BioMarker Strategies's investors include Freemind Investments, Abell Foundation, Inc..
- How much funding has BioMarker Strategies raised?
- BioMarker Strategies has disclosed $525K raised across 1 of its 2 known rounds.
- Where is BioMarker Strategies headquartered?
- BioMarker Strategies is headquartered in Rockville, US.